GABA
A
(gamma‐aminobutyric acid) receptors are fast‐acting, ligand‐gated anion channels that are the major mediators of inhibitory neurotransmission in the mammalian central nervous system as well as essential elements in many nonneuronal cells. A large number of receptor subtypes arise from many subunit classes and isoforms and their respective splice variants. They share many structural and functional attributes with the other members of the pentameric ligand‐gated ion channel superfamily. At this time, the precise number and structures of native receptor subtypes are still not known. GABA
A
receptor subtype activity is additionally regulated by phosphorylation as well as being modulated allosterically by a variety of small molecules including benzodiazepines, chemically very diverse plant compounds, endogenous and synthetic neuroactive steroids and many more. Genetic or adaptive alterations in subunit primary structures, expression or receptor function have been implicated in many phenotypes.
Key Concepts
Nineteen mammalian GABR genes and their splice isoforms encode GABA
A
receptor subunits that are assembled into glycosylated homo or heteropentameric GABA‐gated anion channels, constituting the largest family of mammalian ligand‐gated ion channels.
Expression of GABR genes is tightly regulated during development, uniquely different for individual cell types and modulated by internal and environmental stimuli ranging from hormonal status to factors such as temperature, stress or many medications.
Genetic findings imply altered GABA
A
receptor signalling to be a contributing factor to many different phenotypes including diverse epilepsies, addiction risks and many more.
GABA
A
receptor subunits share a common domain organisation with all other members of the pentameric ligand‐gated ion channel superfamily comprising a large extracellular domain, a transmembrane domain of four transmembrane helices (M1–M4) and an intracellular domain that is highly variable and contains a multitude of regulatory and protein–protein interaction sites.
On each pentamer, depending on its subunit composition, one to five agonist binding sites and many allosteric binding sites exist that impart on each GABA
A
receptor subtype a uniquely distinct pharmacological profile.
The transient kinetic properties of GABA
A
receptors depend on the subunit composition, absence or presence of allosteric modulators such as neuroactive steroids and the phosphorylation state of the individual subunits.
Synaptic GABA
A
receptors are clustered at the postsynaptic membrane and mediate phasic inhibition, namely a fast response to presynaptic GABA release.
Extrasynaptic GABA
A
receptors that are located away from synapses mediate tonic inhibition and are continuously activated by varying low concentrations of GABA, and thus regulating neuronal excitability.